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Osteogenesis imperfecta (OI) is a rare hereditary connective tissue disease primarily characterized with osseous fragility and fractures with an incidence of approximately 
1 in 20,000 [1]. The spectrum of OI is extremely broad, ranging 
from the forms that are lethal in the perinatal period to a mild 
form [1]. Due to its clinical heterogeneity, Sillence classified 
the disease into four Types, I, II, III, and IV, based on clinical 
and radiographic findings [2]. Type I OI is the mildest form of 
the disease, which results from null mutations in COL1A1 or 
COL1A2 where patients may experience bone fractures but have 
fewer deformities. Type II OI is the most severe-lethal form; 
resulting from structural and spontaneous mutations in COL1A1 or 
COL1A2 in which most of the infants fail to survive either before 
birth or immediately after birth. Type III and IV forms of OI are 
progressively deforming, with severe skeletal deformities in some 
individuals [3,4], inherited in an autosomal dominant fashion.
New additional OI phenotypes, Types V, VI, VII, and 
VIII [3,5-7], have been added to the list; these phenotypes do 
not fall into the classical OI phenotypes, originally described by 
Sillence [2,5,6]. Type V OI is inherited in an autosomal dominant 
pattern wherein the patients exhibit hyperplastic callus formation 
and mineralization of the interosseous membrane [6]. Type VI 
OI has an autosomal recessive form, where patients sustain 
more frequent fractures than patients with OI Type IV. Types 
VII and VIII OI result from defects in the prolyl 3-hydroxylation 
complex [7]. Type VII OI results from defects in cartilage-
associated protein, while Type VIII, identified in patients of West 
African origin, is due to a null mutation in LEPRE1, a gene that 
encodes prolyl 3-hydroxylase 1 [7].
Other features include blue sclera, otosclerosis with hearing 
loss, high-arched palate, hyperlaxity of ligaments and skin, 
“dentinogenesis imperfecta” (defective dentition), scoliosis, 
and growth retardation [8]. The major radiographic features are 
generalized osteopenia, delayed or almost absent calvarial bone 
formation, platyspondyly (collapsed vertebral bodies), small 
thorax, continuously beaded ribs, and crumpled and broad tubular 
bones [9].
CASE REPORT
A 2600 g term female neonate delivered by a 22-year-old para 
2 female was admitted to the newborn special care unit with 
dysmorphic facies and an abnormal body posture. Her mother 
received routine antenatal care, iron and folic acid tablets, 
and calcium supplementation, and pregnancy was uneventful. 
Prenatal ultrasonography detected rhizomelic shortening of long 
bones, i.e., both humerus and femur. It was a spontaneous normal 
vaginal delivery and APGAR score was 7 at 1 min and 8 at 5 min 
of birth. There was no obstruction, cephalopelvic disproportion 
which could lead to any fractures during birth. No significant 
family history shown in the pedigree chart.
Examination of the baby revealed an appropriate, for gestational 
age, baby weighing 2.6 kg, in a “frog-like position” (Fig. 1). She 
was pink and afebrile with mild subcostal retractions. Her head, 
however, appeared disproportionately large, with the circumference 
of 32 cm (Fig. 2). The ponderal index was 35.09 and also, the anterior 
and posterior fontanels were palpable, soft, and the sutures were 
slightly widened. Both lower and upper limbs were short, irregular, 
and curved medially with extra skin creases. The baby was shown 
irritated behavior with excessive cry on touch indicating tenderness 
of limbs and incomplete Moro’s reflex. The baby maintained 
normal vitals and did not require oxygen support. Investigations 
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of skeletal dysplasia [3]. The studied partied was found to have 
reduced mineralization of the calvarium, wide open fontanelles, 
and severe micromelia, with abnormal limb posture and 
multiple skin creases. Important differential diagnoses consist 
of OI, thanatophoric dysplasia, hypophosphatasia, campomelic 
dysplasia, and achondrogenesis Type I. Thanatophoric dysplasia 
is the most common form of lysergic acid diethylamide; it is 
characterized by extremely short limbs, macrocephaly, small 
chest, platyspondyly, and cloverleaf skull in some cases. The 
femurs are short and curved having typical “telephone receiver” 
appearance. Ossification of the bones is normal and no fractures 
are present. However, our patient had severe hypomineralized 
skull with multiple fractures of the ribs and long bones.
Infantile type - hypophosphatasia manifests in utero. It 
is characterized by severe hypomineralization of all bones, 
micromelia, and low serum alkaline phosphatase levels [4]. 
Figure 2: The baby on admission with dysmorphic clinical findings: 
Disproportioned large head, low-set ears, severely shortened limbs, 
and small chest with protuberant belly Figure 4: Skull appears enlarged with increased convolution markings with thinning of the cortex
Figure 3: Infantogram showing Inferior limbs X-ray with multiple 
fractures of tibia, fibula and bilateral femur, and upper limb with 
curved bones, Bell shaped thorax and thinning of cortex of skull bone
Figure 1: Frog-like position of the newborn, with curved short limbs 
done included an infantogram, full blood count, packed cell volume, 
white blood cell and differentials, electrolyte, urea, and creatinine. 
The alkaline phosphatase levels were 181 U/L, serum calcium was 
8.55 mg/dL, and phosphorus levels were 4.9 mg/dL. Radiographic 
examination confirmed the diagnosis of OI.
The infantogram (X-ray) revealed a bell-shaped thorax with 
widening of anterior end of all ribs; all long bones, showing 
cortical irregularity with callus formation and deformity, were in 
the evidence of multiple diaphyseal fractures (Fig. 3). The skull 
appeared enlarged with increased convolution markings and 
thinning of the cortex (Fig. 4). All the above findings were in 
favor of possible OI.
DISCUSSION
Clinical examination and radiographic assessment of the skull, 
spine, thorax, limbs, and pelvis are essential to identify the type 
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However, in our patient, severe hypomineralization of the 
calvarium was present with normal alkaline phosphatase values. 
Clinical and radiological features of our patient were strongly 
suggestive of OI; classical OI was described with the triad of 
fragile bones, blue sclera, and early deafness, although, most 
cases do not have all of these features [10].
Prenatal diagnosis of OI may be performed by chorionic villus 
sampling with analysis of collagen synthesis of fetal cells between 
10 and 12 weeks of gestational age by DNA testing, protein-based 
testing of the collagen in weeks 12–14, or even by ultrasonography 
to identify OI Types II, III, and IV. The diagnosis after birth is 
mainly done with the clinical picture, radiological features, and 
a significant family history. Severe OI can be detected prenatally 
by level II ultrasonography as early as 16 weeks of gestation. It 
is a possibility that OI might be misunderstood as thanatophoric 
dysplasia. For recurrent cases, chorionic villus biopsy can be 
used for biochemical or molecular studies. In the neonatal period, 
the normal to elevated alkaline phosphatase levels present in OI 
distinguishing it from hypophosphatasia [11].
There is no cure for OI, but there are three types of treatment 
available: Non-surgical management (physical therapy, 
rehabilitation, bracing, and splinting), surgery (intramedullary rod 
positioning), and drugs to increase the strength of bone and decrease 
the number of fractures. For severe non-lethal OI, active physical 
rehabilitation, in the early years, allows children to attain a higher 
functional level than orthopedic management alone. Children with 
OI Type I and some with Type IV are spontaneous ambulators. In 
recent years, growth hormone (GH) and bisphosphonate agents 
have been used in OI therapy. GH is beneficial in patients with 
moderate forms of OI, showing a positive effect on bone turnover, 
bone mineral density, and height velocity rate. Bisphosphonates 
(IV pamidronate or oral olpadronate or risedronate) have proved 
beneficial in children with severe OI, increasing bone mineral 
density, and reducing the fracture rate and pain while showing 
no adverse effects reported. Orthopedic management of OI is 
aimed at fracture management and correction of deformity to 
enable function. Fractures should be promptly splinted or cast; 
OI fractures heal well, and cast removal should be aimed at 
minimizing immobilization osteoporosis. Correction of long bone 
deformity requires an osteotomy procedure and placement of an 
intramedullary rod [12].
Stem cells have generated great interest and excitement 
because of the potential they possess in regenerative medicine. 
Application of stem cells to treat OI is attractive; the rationale 
for treating OI with stem cells is that osteoblasts in the bones of 
OI patients can be replaced with normal cells that will synthesize 
normal bone matrix and thus normalize tissue function. This 
is possible because normal cells will have a growth advantage 
over the endogenous cells that synthesize defective matrix. 
For OI cell therapy, it is not clear which cells are suitable to 
transplant. A combination of gene and cell therapy may offer the 
best approach due to the complexity of the OI disease. This is a 
challenge because methods to direct embryonic stem cells (ESCs) 
to the desired cell lineages are poorly understood at present. The 
application of ESCs for OI treatment, therefore, remains a future 
possibility [6,7].
CONCLUSION
It is a group of rare inherited disorders of connective tissue 
with the hallmark of excessive fragility of bones characterized 
by remarkable soft and large cranium and short-curved limbs. 
Radiological findings including under mineralization of skull, 
platyspondyly, severely short and deformed long bones, and small 
continuously beaded ribs are pathognomonic of OI.
 REFERENCES
1. Marini JC. Ontogenesis imperfecta. In: Kliegman RM, Geme ST, Schor S, 
editors. Nelson Textbook of Pediatrics. 20thed. Philadelphia, PA: WB 
Saunders; 2000. p. 5172-6.
2. Steiner RD, Pepin MG, Byers PH. Osteogenesis imperfecta. In: Pagon RA, 
Bird TC, Dolan CR, Stephens K, editors. Gene Reviews. Seattle (WA): 
University of Washington, Seattle; 2005.
3. Puri RD, Thakur S, Verma IC. Spectrum of severe skeletal dysplasias in 
North India. Indian J Pediatr 2007;74:995-1002.
4. Mornet E. Hypophosphatasia. Orphanet J Rare Dis 2007;2:40.
5. Rauch F, Glorieux FH. Osteogenesis imperfecta, current and future medical 
treatment. Am J Med Genet C Semin Med Genet 2005;139C:31-7.
6. Hochedlinger K, Rideout WM, Kyba M, Daley GO, Blelloch R, Jaenisch R/
Nuclear transplantation, embryonic stem cells and potential for cell therapy. 
Hematol J 2004;5:S114-7.
7. Niyibizi C, Li F. Potential implications of cell therapy for osteogenesis 
imperfecta. Int J Clin Rheumtol 2009;4:57-66.
8. Polousky JD, Eilert RE. Orthopedics. In: Hay WW, Levin MJ, 
Sondheimer JM, Deterding RR, editors. Current Pediatrics: Diagnosis and 
Treatment. 19th ed. Vol. 753. New York: McGraw Hill; 2009. p. 1005-6.
9. Byrne JB. Osteogenesis Imperfecta. 1st ed. London: Academic Press; 2005. 
p. 10-20.
10. Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, et al. 
Osteogenesis imperfecta type VII: An autosomal recessive form of brittle 
bone disease. Bone 2002;31:12-8.
11. Morgan JA, Marcus PS. Prenatal diagnosis and management of intrauterine 
fracture. Obstet Gynecol Surv 2010;65:249-59.
12. Monti E, Mottes M, Fraschini P, et al. Current and emerging treatments 
for the management of osteogenesis imperfecta. Ther Clin Risk Manag 
2010;6:367-81.
Funding: None; Conflict of Interest: None Stated.
How to cite this article: Goyal S, Meena P, Mehrotra J, Malvia S, Rawat R, 
Meena M, Dodiyar R. Brittle bone disease - A rare genetic disorder: A case 
report. Indian J Child Health. 2018; 5(8):551-553.
